Bortezomib ttProteasom

LE WE PMID CA

Bortezomib ttProteasom

4359

Bortezomib ttProteasom

Alcohol

Bacitracin ttPDI

Bortezomib ttProteasom

Cetuximab ttEGFR

Dickkopf1

ERS UFR (Apoptosis)

ERS UFR (Pharmacology)

Fenretinide

HDAC6

Heart (Toxicology)

KLF9

Lung and bronchial system (Neoplasia)

Noxa

Osteoblasts

Osteoclasts

Osteoporosis

P4HB procollagen proline 2 oxoglutarate 4 dioxygenase beta subunit

Panobinostat LBH589 ttHDAC

PCD (Multiple myeloma and other plasma cell dyscrasias)

Pemetrexed

Proteasome (BASKET)

Protein disulfide isomerase

Skin (Neoplasia Melanoma)

Suberoylanilide hydroxamic acid ttHDAC6

Tipifarnib

Transplantation

Ubiquitin

2009 1	Bortezomib for the treatment of multiple myeloma patients. [19567211] Health Technol Assess 13 Suppl 1(-): 29-33 (2009)
2007 2	Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature. [17654660] Cancer 110(5): 1042-9 (2007)
2011 3	Potential usage of proteasome inhibitor bortezomib (Velcade, PS-341) in the treatment of metastatic melanoma: basic and clinical aspects. [22016836] Am J Cancer Res 1(7): 913-24 (2011)
2009 4	Nuclear effects of ethanol-induced proteasome inhibition in liver cells. [19291815] World J Gastroenterol 15(10): 1163-7 (2009)
2007 5	Myeloma bone disease and proteasome inhibition therapies. [17494860] Blood 110(4): 1098-104 (2007)
2008 6	Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. [18574024] Blood 112(5): 1593-9 (2008)
2007 7	Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. [18024368] Haematologica 92(10): 1308-10 (2007)
2006 8	A practical update on the use of bortezomib in the management of multiple myeloma. [16401713] Oncologist 11(1): 51-61 (2006)
2007 9	Clinical impact of bortezomib in frontline regimens for patients with multiple myeloma. [17766658] Oncologist 12(8): 978-90 (2007)
2007 10	The emerging role of targeted therapy for hematologic malignancies: update on bortezomib and tipifarnib. [17405892] Oncologist 12(3): 281-90 (2007)
2005 11	Three emerging new drugs for NSCLC: pemetrexed, bortezomib, and cetuximab. [15821248] Oncologist 10(4): 282-91 (2005)
2011 12	Role of proteasome inhibition in sensitized transplant candidates. [21518574] Chin Med J (Engl) 124(5): 771-4 (2011)
2010 13	Cardiotoxicity of the anticancer therapeutic agent bortezomib. [20519734] Am J Pathol 176(6): 2658-68 (2010)
2012 14	KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells. [22144178] Blood 119(6): 1450-8 (2012)
2008 15	Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. [18593938] Cancer Res 68(13): 5363-9 (2008)
2006 16	Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells. [16585204] Cancer Res 66(7): 3773-81 (2006)
2009 17	The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response. [19228726] Clin Cancer Res 15(4): 1199-209 (2009)
2009 18	Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma. [19228725] Clin Cancer Res 15(4): 1192-8 (2009)
2006 19	Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia. [16428505] Clin Cancer Res 12(2): 591-9 (2006)
2010 20	Bortezomib in kidney transplantation. [20953363] J Transplant 2010(-): - (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Bortezomib ttProteasom.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Bortezomib ttProteasom.php on line 92